Abstract
A blood pressure fall of 6-8/4-6 mmHg is seen when a beta-blocker is added to a thiazid or a calcium antagonist. Due to less protection against cardiovascular complications, most likely explained by an insufficient reduction in the central aortic blood pressure profile betablockers, especially atenolol, is no longer first choice treatment for hypertension, unless ischaemic heart disease or heart failure is present.
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / therapeutic use*
-
Adult
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / therapeutic use*
-
Blood Pressure / drug effects
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / therapeutic use*
-
Drug Therapy, Combination
-
Evidence-Based Medicine
-
Heart Rate / drug effects
-
Humans
-
Hypertension / drug therapy*
-
Sodium Chloride Symporter Inhibitors / administration & dosage
-
Sodium Chloride Symporter Inhibitors / therapeutic use*
Substances
-
Adrenergic beta-Antagonists
-
Antihypertensive Agents
-
Calcium Channel Blockers
-
Sodium Chloride Symporter Inhibitors